1. Home
  2. BNR vs NMI Comparison

BNR vs NMI Comparison

Compare BNR & NMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

N/A

Current Price

$13.00

Market Cap

141.5M

Sector

Health Care

ML Signal

N/A

Logo Nuveen Municipal Income Fund Inc.

NMI

Nuveen Municipal Income Fund Inc.

N/A

Current Price

$9.61

Market Cap

114.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BNR
NMI
Founded
2014
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
141.5M
114.5M
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
BNR
NMI
Price
$13.00
$9.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
23.4K
★ 68.5K
Earning Date
11-23-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$101.46
N/A
Revenue Next Year
$14.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.79
$9.10
52 Week High
$41.72
$11.28

Technical Indicators

Market Signals
Indicator
BNR
NMI
Relative Strength Index (RSI) 51.21 57.21
Support Level $9.12 $9.10
Resistance Level $19.10 $10.97
Average True Range (ATR) 1.26 0.20
MACD 0.16 0.05
Stochastic Oscillator 88.67 79.69

Price Performance

Historical Comparison
BNR
NMI

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About NMI Nuveen Municipal Income Fund Inc.

Nuveen Municipal Income Fund Inc is a diversified, closed-end management investment company. The Fund's investment objective is to provide a high level of current income exempt from federal income tax, which it seeks to achieve by investing mainly in a diversified portfolio of tax-exempt municipal obligations.

Share on Social Networks: